BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 19944586)

  • 1. Variability of marker-based rectal dose evaluation in HDR cervical brachytherapy.
    Wang Z; Jaggernauth W; Malhotra HK; Podgorsak MB
    Med Dosim; 2010; 35(4):269-73. PubMed ID: 19944586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Point vs. volumetric bladder and rectal doses in combined intracavitary-interstitial high-dose-rate brachytherapy: correlation and comparison with published Vienna applicator data.
    Yaparpalvi R; Mutyala S; Gorla GR; Butler J; Mah D; Garg MK; Kalnicki S
    Brachytherapy; 2008; 7(4):336-42. PubMed ID: 18782683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of brachytherapy practice for patients with carcinoma of the cervix (1996-1999): a patterns of care study.
    Erickson B; Eifel P; Moughan J; Rownd J; Iarocci T; Owen J
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1083-92. PubMed ID: 16099599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total reference air kerma: to what extent can it predict intracavitary volume enclosed by isodose surfaces during multiple high-dose rate brachytherapy?
    Datta NR; Das KJ; Basu R; Singh U
    Brachytherapy; 2003; 2(2):91-7. PubMed ID: 15062146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Image-guided cervix high-dose-rate brachytherapy treatment planning: does custom computed tomography planning for each insertion provide better conformal avoidance of organs at risk?
    Davidson MT; Yuen J; D'Souza DP; Batchelar DL
    Brachytherapy; 2008; 7(1):37-42. PubMed ID: 18299111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of rectal dose during high-dose-rate intracavitary brachytherapy for cervical carcinoma.
    Sha RL; Reddy PY; Rao R; Muralidhar KR; Kudchadker RJ
    Med Dosim; 2011; 36(4):377-82. PubMed ID: 21144733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3D CT-based volumetric dose assessment of 2D plans using GEC-ESTRO guidelines for cervical cancer brachytherapy.
    Gao M; Albuquerque K; Chi A; Rusu I
    Brachytherapy; 2010; 9(1):55-60. PubMed ID: 19853536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison of calculated and measured rectal doses in HDR brachytherapy with Ir-192 source].
    Kakinohana Y; Toita T; Ogawa K; Yoshinaga M; Iraha S; Zukeran Y; Sawada S
    Nihon Igaku Hoshasen Gakkai Zasshi; 1997 Apr; 57(5):265-70. PubMed ID: 9164116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosimetric analysis at ICRU reference points in HDR-brachytherapy of cervical carcinoma.
    Eich HT; Haverkamp U; Micke O; Prott FJ; Müller RP
    Rontgenpraxis; 2000; 53(2):62-6. PubMed ID: 10994367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of planned and measured rectal dose in-vivo during high dose rate Cobalt-60 brachytherapy of cervical cancer.
    Zaman ZK; Ung NM; Malik RA; Ho GF; Phua VC; Jamalludin Z; Baharuldin MT; Ng KH
    Phys Med; 2014 Dec; 30(8):980-4. PubMed ID: 25086486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dosimetric evaluation of two treatment planning systems for high dose rate brachytherapy applications.
    Shwetha B; Ravikumar M; Supe SS; Sathiyan S; Lokesh V; Keshava SL
    Med Dosim; 2012; 37(1):71-5. PubMed ID: 21719273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dosimetric parameters that predict late rectal complications after curative radiotherapy in patients with uterine cervical carcinoma.
    Hyun Kim T; Choi J; Park SY; Lee SH; Lee KC; Yang DS; Shin KH; Cho KH; Lim HS; Kim JY
    Cancer; 2005 Sep; 104(6):1304-11. PubMed ID: 16078262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical comparison of two linear-quadratic model-based isoeffect fractionation schemes of high-dose-rate intracavitary brachytherapy for cervical cancer.
    Wang CJ; Huang EY; Sun LM; Chen HC; Fang FM; Hsu HC; Changchien CC; Leung SW
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):179-89. PubMed ID: 15093915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inverse planning simulated annealing for magnetic resonance imaging-based intracavitary high-dose-rate brachytherapy for cervical cancer.
    Kubicky CD; Yeh BM; Lessard E; Joe BN; Speight JL; Pouliot J; Hsu IC
    Brachytherapy; 2008; 7(3):242-7. PubMed ID: 18468959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiotherapy doses at special reference points correlate with the outcome of cervical cancer therapy.
    Yoshimura R; Hayashi K; Ayukawa F; Toda K; Iwata M; Oota S; Hoshi A; Wakatsuki M; Kurosaki H; Okazaki A; Shibuya H
    Brachytherapy; 2008; 7(3):260-6. PubMed ID: 18579445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of correlation between rectal complications and rectal dose following high dose rate intracavitary radiotherapy in patients with uterine cervix cancer: in vivo dosimetric analysis.
    Shin KH; Huh SJ; Chie EK; Choi DR; Lim DH; Kim MK; Lee KC; Kim DY; Ahn YC
    Radiat Med; 1999; 17(4):289-93. PubMed ID: 10510902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proposed guidelines for image-based intracavitary brachytherapy for cervical carcinoma: report from Image-Guided Brachytherapy Working Group.
    Nag S; Cardenes H; Chang S; Das IJ; Erickson B; Ibbott GS; Lowenstein J; Roll J; Thomadsen B; Varia M;
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1160-72. PubMed ID: 15519788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is simulation necessary for each high-dose-rate tandem and ovoid insertion in carcinoma of the cervix?
    Jones ND; Rankin J; Gaffney DK
    Brachytherapy; 2004; 3(3):120-4. PubMed ID: 15533802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virtual HDR CyberKnife treatment for localized prostatic carcinoma: dosimetry comparison with HDR brachytherapy and preliminary clinical observations.
    Fuller DB; Naitoh J; Lee C; Hardy S; Jin H
    Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1588-97. PubMed ID: 18374232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single versus customized treatment planning for image-guided high-dose-rate brachytherapy for cervical cancer: dosimetric comparison and predicting factor for organs at risk overdose with single plan approach.
    Chi A; Gao M; Sinacore J; Nguyen NP; Vali F; Albuquerque K
    Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):309-14. PubMed ID: 19540070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.